News
Octapharma has released the results from its prospective, randomized, double-blind, parallel group, crossover, placebo-controlled phase 3 study comparing the effectiveness of PANZYGA® (immune globulin ...
Circulate Health, the company dedicated to harnessing the potential of therapeutic plasma exchange (TPE) to advance human healthspan and lifespan, today announces the publication of a single blind, ...
This pilot clinical trial evaluated safety and tolerability of intravenous immunoglobulin ... Interventions included monthly infusions of the IVIG preparation Privigen®, dose 0.4 gram/kg ...
SCTIMST transfers 5 medical device technologies to industry, including DBS system, electrodes, plasma fractionation, and wound dressings.
Radicle Science, a health tech company bringing trusted clinical evidence to everyday wellness and natural products, welcomes Liya Sharif Lancia as its chief marketing officer. This latest addition to ...
erasmusmc.nl Background Different preparations of intravenous immunoglobulin (IVIg ... report that some IVIg brands are more effective than others. A liquid IVIg preparation is more user friendly and ...
Hyderabad: In a rare medical development, a highly sensitised kidney failure patient in Nandyal, Andhra Pradesh, has ...
Unraveling the Complexities, Risks, and Latest Breakthroughs in Diagnosis and Treatment Introduction to Coxsackievirus: Classification and Virology Epidemiology and Global Distribution Patterns ...
The following is a summary of “Rituximab combined with intravenous immunoglobulin in autoimmune diseases: a systematic review ...
6d
News-Medical.Net on MSNTherapeutic plasma exchange combined with intravenous immunoglobin reduces biological ageA first-of-its-kind clinical trial clinical trial shows that therapeutic plasma exchange (TPE) combined with intravenous ...
Research participants were assigned one of four different treatment groups: 1) biweekly TPE, 2) biweekly TPE with intravenous immunoglobulin (IVIG) 3) monthly TPE or 4) a control group.
Due to the autoimmune etiology of this disorder, IV immunoglobulin (IVIg) or plasma exchange (PE) are the first-line treatments in addition to management of ventilatory failure. IVIg is more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results